Attana will participate at Biotech Showcase™ 2021

Attana will participate at one of the largest biotech conferences in the world – Biotech Showcase™ 2021. Attending the conference are global investors and over a thousand potential customers and strategic partners. 

The conference, this year in a digital form, takes place on January 11 to January 15. Attana will broadcast a 30-minute presentation and then participate in digital one-on-one meetings. Attana will mainly focus on connecting with new customers but also welcome discussions with potential strategic partners and investors. The presentation will also be published on Attana’s website after the conference. 

For more information, please contact: 

Teodor Aastrup, CEO 
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated. 

About Attana 

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in-vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.se or contact sales@attana.com. 

Tags: